cancers-logo

Journal Browser

Journal Browser

Breast Cancer Evolution—Insights from Single-Cell Genomics

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Molecular Cancer Biology".

Deadline for manuscript submissions: 30 June 2026 | Viewed by 239

Special Issue Editor


E-Mail Website
Guest Editor
Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA
Interests: breast cancer; biomarker; targeted therapy; endocrine resistance; personalized therapy strategies

Special Issue Information

Dear Colleagues,

Breast cancer is a highly heterogeneous disease shaped by dynamic evolutionary processes arising from intrinsic genomic instability, microenvironmental cues, and therapeutic intervention. Recent advances in single-cell genomics, including single-cell RNA-seq, ATAC-seq, multi-omics profiling, and spatially resolved technologies, allow unprecedented resolution of tumor ecosystems. These approaches reveal rare subclones, lineage plasticity, stromal–immune interactions, and early adaptive responses that drive treatment resistance and metastasis. This Special Issue highlights emerging insights into breast cancer evolution gained through single-cell technologies, spanning primary and metastatic disease, therapy resistance, immune microenvironment remodeling, and biomarker discovery. Together, these studies underscore the transformative potential of single-cell analysis to inform personalized therapy and guide next-generation clinical trials.

Prof. Dr. Cynthia Ma
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • single-cell genomics
  • tumor evolution
  • intratumoral heterogeneity
  • lineage plasticity
  • therapy resistance
  • spatial transcriptomics
  • tumor microenvironment
  • clonal dynamics
  • multi-omics profiling

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop